INOVIO PHARMACEUTICALS, INC.

Pharmaceutical preparations for use in the treatment of recurrent respiratory papillomatosis (RRP); injectable pharmaceutical preparations for use in the treatment of recurrent respiratory papillomatosis (RRP).

Pharmaceutical preparations for use in the treatment of recurrent respiratory papillomatosis (RRP); injectable pharmaceutical preparations for use in the treatment of recurrent respiratory papillomatosis (RRP).

scientific testing and analysis of cGMP processes in the field of nucleic acids including DNA plasmids and of the nucleic acid molecules produced by such processes; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicine

scientific testing and analysis of cGMP processes in the field of nucleic acids including DNA plasmids and of the nucleic acid molecules produced by such processes; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines

Pharmaceutical preparations comprising nucleic acid encoded monoclonal antibody proteins produced in vivo for the treatment of cancers, genetic disorders, infectious diseases, and chronic diseases

Vaccine preparations; Vaccines; Pharmaceuticals, namely, pharmaceutical products, preparations and substances for the prevention and treatment of cancer and infectious diseases

Pharmaceutical preparations for human use for the treatment and prevention of cancer and infectious diseases; pharmaceutical preparations for human use, namely, antibiotics, antifungals and anti-virals | Providing health information to health care professionals and patients

Pharmaceutical compositions for the prevention and treatment of acquired immunodeficiency syndrome, cancer and infectious diseases; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of acquired immunodeficiency syndrome (AIDS)

"THERAPEUTICS"

Class 040: Custom manufacture of nucleic acids including DNA plasmids, and current good manufacturing practice (cGMP) quality nucleic acids including DNA plasmids, to the order or specification of others; Class 042: Testing, analysis and evaluation of the goods and services of others for the purpose of certification, namely, testing and analysis of current good manufacturing practice (cGMP) processes of others used in the production of nucleic acid molecules and testing and analysis of the nucleic acids molecules produced by such processes

Nucleic acid sequences and chemical reagents for medical and veterinary purposes, specifically excluding chemical reagents for clinical diagnostic medical purposes

Medical apparatus for delivering nucleic acid molecules, for example plasmids, or vaccines to mammals or cells via electroporation

Medical apparatus for use in delivering drugs or genes to cellular structures by means of electroporation

"DNA ELECTROPORATION THERAPY SYSTEM"

pharmaceutical preparations of modified steroid hormone receptors for medical use in gene therapy and clinical medical laboratory use

Class 042: Research and development in the fields of pharmaceuticals, biopharmaceuticals and therapeutics; Research and development in the field of personalized medicine and its delivery to patients; Research and development in the field of oncology; Research and development of personalized cancer treatments; Medical and scientific research, namely, conducting clinical trials for others; Research and development of treatments for infectious diseases